Jonathan Chung to Genomics
This is a "connection" page, showing publications Jonathan Chung has written about Genomics.
Connection Strength
1.012
-
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas. Urol Oncol. 2021 10; 39(10):731.e1-731.e15.
Score: 0.135
-
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms. Clin Cancer Res. 2021 06 01; 27(11):3094-3105.
Score: 0.132
-
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 01 15; 203(2):211-220.
Score: 0.131
-
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling. Lung Cancer. 2020 10; 148:69-78.
Score: 0.127
-
Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic Profiling. Clin Genitourin Cancer. 2020 06; 18(3):e289-e292.
Score: 0.121
-
Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart. Oncologist. 2019 04; 24(4):e142-e145.
Score: 0.114
-
Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA. J Mol Diagn. 2018 09; 20(5):686-702.
Score: 0.110
-
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma. Urol Oncol. 2021 06; 39(6):367.e1-367.e5.
Score: 0.033
-
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. Oncologist. 2019 06; 24(6):791-797.
Score: 0.028
-
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 02; 14(2):255-264.
Score: 0.028
-
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018 09; 50(9):1234-1239.
Score: 0.028
-
Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma. J Natl Compr Canc Netw. 2017 05; 15(5):555-562.
Score: 0.025